2022業績

2022年1月

  1. Factors influencing the quality of life in patients with severe dementia.
    Nagata Y, Nishikawa T, Tanaka H, Ishimaru D, Ogawa Y, Fukuhara K, Shigenobu K, Ikeda M.
    Psychogeriatrics. 22(1):49-54. 2022.1.
  2. Experts' perception of support for people with dementia and their families during the COVID-19 pandemic.
    Kazawa K, Akishita M, Ikeda M, Iwatsubo T, Ishii S
    Geriatrics & gerontology international.22(1)26-31. 2022.1
  3. Using a Non-Wearable Actigraphy in Nursing Care for Dementia With Lewy Bodies
    Fukuda C, Higami Y, Shigenobu K, Kanemoto H, Yamakawa M.
    Am J Alzheimers Dis Other Demen. 37:15333175221082747. 2022.1.-12.
  4. Hippocampal subfield volumes and cognitive function in schizophrenia and mood disorders
    Yasuda K, Yamada S, Uenishi S, Ikeda N, Tamaki A, Ohoshi Y, Tsuji T, Takahashi S
    Neuropsychobiology.81(3):204-214., 2022.1.14
  5. Neural advantages of older musicians involve the cerebellum: Implications for healthy aging through lifelong musical instrument training.
    Yamashita M, Ohsawa C, Suzuki M, Guo X, Sadakata M, Otsuka Y, Asano K, Abe N, Sekiyama K
    Front Hum Neurosci. 15:784026. 2022.1.5
  6. Using a Non-Wearable Actigraphy in Nursing Care for Dementia With Lewy Bodies. American journal of Alzheimer's disease and other dementias.
    Fukuda C, Higami Y, Shigenobu K, Kanemoto H, Yamakawa M.
    American journal of Alzheimer's disease and other dementias. 37; 15333175221082747. 2022.1.-12.

2022年2月

  1. Magnetoencephalography detects phase-amplitude coupling in Parkinson's disease.
    Tanaka M, Yanagisawa T, Fukuma R, Tani N, Oshino S, Mihara M, Hattori N, Kajiyama Y, Hashimoto R, Ikeda M, Mochizuki H, Kishima H.
    Sci Rep. 12(1):1835. 2022.2.3
  2. Editorial: Biological Basis and Therapeutics of Behavioral and Psychological Symptoms of Dementia.
    Davalos D, Teixeira A, Ikeda M
    Front Psychiatry. 10; 13:838962. 2022.2
  3. Unclassified fluent variants of primary progressive aphasia: distinction from semantic and logopenic variants
    Watanabe H, Hikida S, Ikeda M, Mori E
    Brain Communications. 4(3):fcac015. 2022.2.2
  4. Schizophrenia after remission of anti-NMDA receptor encephalitis
    Yasuda K, Uenishi S, Sakamoto H, Hori K, Koh J, Takahashi S
    Asian J Psychiatr. 70:103027, 2022.2.12
  5. Parietal Gamma Band Oscillation Induced by Self-Hand Recognition.
    Ueda M, Ueno K, Inamoto T, Shiroma C, Hata M, Ishii R, Naito Y.
    Brain Sci. 12(2):272. 2022.2.16
  6. Automatic Thoughts and Facial Expressions in Cognitive Restructuring with Virtual Agents.
    Shidara K, Tanaka H, Adachi H, Kanayama D, Sakagami Y, Kudo T, Nakamura S
    Frontiers in Computer Science.4: 762424. 2022

2022年3月

  1. A prospective multicenter validation study of a machine learning algorithm classifier on quantitative electroencephalogram for differentiating between dementia with Lewy bodies and Alzheimer's dementia
    Suzuki Y, Suzuki M, Shigenobu K, Shinosaki K, Aoki Y, Kikuchi H, Baba T, Hashimoto M, Araki T, Johnsen K, Ikeda M, Mori E
    PLOS ONE. 17(3) e0265484.2022.3.31.
  2. Normalized Power Variance: A new Field Orthogonal to Power in EEG Analysis
    Aoki Y, Kazui H, Pascual-Marqui RD, Bruña R, Yoshiyama K, Wada T, Kanemoto H, Suzuki Y, Suehiro T, Satake Y, Yamakawa M, Hata M, Canuet L, Ishii R, Iwase M, Ikeda M.
    Clin EEG Neurosci. 15500594221088736. 2022.3.29
  3. Response to the letter "The effect of Alzheimer's disease comorbidity in tap test response in idiopathic normal pressure hydrocephalus?" from Dr. Onder et al.
    Kanemoto H, Mori E, Ikeda M
    International psychogeriatrics. 1-2. 2022.3.28
  4. Case Report: Treatment of Delusions of Theft Based on the Assessment of Photos of Patients' Homes.
    Ishimaru D, Kanemoto H, Hotta M, Nagata Y, Satake Y, Taomoto D, Ikeda M
    Frontiers in psychiatry. 13:825710. 2022.3.17.
  5. Neurocognitive features, personality traits, and social function in patients with schizophrenia with a history of violence
    Kashiwagi H, Matsumoto J, Miura K, Takeda K, Yamada Y, Fujimoto M, Yasuda Y, Yamamori H, Ikeda M, Hirabayashi N, Hashimoto R
    Journal of Psychiatric Research. 147:50-58. 2022.3
  6. Subjective assessment of participants in education programs on clin-ical practice guidelines in the field of psychiatry.
    Ogasawara K, Numata S, Hasegawa N, Nakataki M, Makinodan M, Ohi K, Takeshima M, Tsuboi T, Hashimoto N, Onitsuka T, Muraoka H, Hori H, Ichihashi K, Inagaki T, Yasui-Furukori N, Hishimoto A, Sugiyama N, Fukumoto K, Nagasawa T, Matsumoto J, Takaesu, Y, Furihata R, Nemoto K, Nakamura T, Usami M, Miura K, Fujimoto M, Tagata H, Yamada H, Komatsu H, Ochi S, Atake K, Katsumoto E, Kido M, Kishimoto T, Suwa T, Yamamura S, Iga J I, Iida H, Inada K, Watanabe K, Hashimoto, R.
    Neuropsychopharmacology reports, 42(2):221-225, 2022.3.10

2022年4月

  1. An autopsy case of Alzheimer's disease with amygdala-predominant Lewy pathology presenting with frontotemporal dementia-like psychiatric symptoms.
    Beck G, Shigenobu K, Ukon K, Yonenobu Y, Morii E, Hasegawa M, Ikeda M, Murayama S, Mochizuki H
    Neuropathology. 42(2):147-154. 2022.4
  2. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism.: a randomized trial.
    Yamasue H, Kojima M, Kuwabara H, Kuroda M, Matsumoto K, Kanai C, Inada N, Owada K, Ochi K, Ono N, Benner S, Wakuda T, Kameno Y, Inoue J, Harada T, Tsuchiya K, Umemura K, Yamauchi A, Ogawa N, Kushima I, Ozaki N, Suyama S, Saito T, Uemura Y, Hamada J, Kano Y, Honda N, Kikuchi S, Seto M, Tomita H, Miyoshi N, Matsumoto M, Kawaguchi Y, Kanai K, Ikeda M, Nakamura I, Isomura S, Hirano Y, Onitsuka T, Kosaka H, Okada T.
    Brain. 145(2):490-499. 2022.4.18.
  3. Relationship between autistic traits and social functioning in healthy individuals.
    Demizu Y, Matsumoto J, Yasuda Y, Ito S, Miura K, Yamamori H, Fujimoto M, Hasegawa N, Ishimaru K, Hashimoto R.
    Neuropsychopharmacology reports, 42(2):226-229, 2022.4.1
  4. A dissemination and education programme to improve the clinical be-haviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treat-ment (EGUIDE) project.
    Yamada H, Motoyama M, Hasegawa N, Miura K, Matsumoto J, Ohi K, Yasui-Furukori N, Numata S, Takeshima M, Sugiyama N, Nagasawa T, Kubota C, Atake K, Tsuboi T, Ichihashi K, Hashimoto N, Inagaki T, Takaesu Y, Iga J I, Hori H, Onitsuka T, Komatsu H, Hishimoto A, Fukumoto K, Fujimoto M, Nakamura T, Nemoto K, Furihata R, Yamamura S, Yamagata H, Ogasawara K, Katsumoto E, Murata A, Iida H, Ochi S, Makinodan M, Kido M, Kishimoto T, Yasuda Y, Usami M, Suwa T, Inada K, Watanabe K, Hashimoto R.
    BJPsych Open. 8(3):e83. 2022.4.21
  5. Differences in electric field strength between clinical and non-clinical populations induced by prefrontal tDCS: a cross-diagnostic, individual MRI-based modeling study
    Mizutani-Tiebel Y, Takahashi S, Karali T, Mezger E, Bulubas L, Papazova I, Dechantsreiter E, Stoecklein S, Papazov B, Thielscher A, Padberg F, Keeser D
    Neuroimage Clin. 34:103011, 2022.4.16
  6. Age-dependent genetic variants associated with longitudinal changes in brain structure across the lifespan
    Brouwer RM, ..., Takahashi S（201人中80番目）, ..., Hulshoff Pol HE
    Nat Neurosci. 25(4):421-432, 2022.4.25
  7. Early initiation of rivaroxaban after reperfusion therapy for stroke patientswith nonvalvular atrial fibrillation
    Koge J, Yamagami H, Toyoda K, Yasaka M, Hirano T, Hamasaki T, Nagao T, Yoshimura S, Fujishige M, Tempaku A, Uchiyama S, Mori E, Koga M, Minematsu K
    PLoS One. 17(4):e0264760, 2022.4.6

2022年5月

  1. Brain structural alterations and clinical features of cognitive frailty in Japanese community-dwelling older adults: the Arao study (JPSC-AD).
    Yoshiura K, Fukuhara R, Ishikawa T, Tsunoda N, Koyama A, Miyagawa Y, Hidaka Y, Hashimoto M, Ikeda M, Takebayashi M, Shimodozono M
    Scientific reports. 12(1) 8202. 2022.5.17.
  2. Plasma NfL is associated with mild cognitive decline in patients with diabetes.
    Marutani N, Akamine S, Kanayama D, Gotoh S, Yanagida K, Maruyama R, Mori K, Miyamoto T, Adachi H, Sakagami Y, Yoshiyama K, Hotta M, Nagase A, Kozawa J, Maeda N, Otsuki M, matsuoka T, Iwahashi H, Shimomura I, Murayama N, Watanabe H, Ikeda M, Mizuta I, Kudo T
    Psychogeriatrics. 22(3):353-359. 2022.5
  3. An international consensus statement on the benefits of reframing aging and mental health conditions in a culturally inclusive and respectful manner.
    Peisah C, de Mendonça Lima CA, Ayalon L, Banerjee D, De Leo D, Hwang TJ, Ikeda M, Jeste D, Leon T, Wang H, Warner J, Rabheru K.
    International Psychogeriatr. 1-4. 2022.5.26.
  4. TMS Database Registry Consortium Research Project in Japan (TReC-J) for Future Personalized Psychiatry
    Noda Y, Kizaki J, Takahashi S, Mimura M
    J Pers Med. 12(5):844, 2022.5.22
  5. Bridging Therapy With Heparin Before Starting Rivaroxaban in Ischemic Stroke orTransient Ischemic Attack With Non-Valvular Atrial Fibrillation
    Tokunaga K, Yasaka M, Toyoda K, Mori E, Hirano T, Hamasaki T, Yamagami H, Nagao T, Yoshimura S, Uchiyama S, Minematsu K; RELAXED Study Investigators
    Circ J. 86(6):958-963, 2022.5.25

2022年6月

  1. Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (G4C2)n expression in C9orf72 ALS/FTD
    Czuppa M, Dhingra A, Zhou Q, Schludi C, König L, Scharf E, Farny D, Dalmia A, Täger J, Castillo-Lizardo M, Katona E, Mori K, Aumer T, Schelter F, Müller M, Carell T, Kalliokoski T, Messinger J, Rizzu P, Heutink P, Edbauer D.
    Cell Reports 39, 110913, 2022.6.7
  2. Transdiagnostic comparisons of intellectual abilities and work out-come in patients with mental disorders: multicentre study.
    Sumiyoshi C, Ohi K, Fujino H, Yamamori H, Fujimoto M, Yasuda Y, Uno Y, Takahashi J, Morita K, Katsuki A, Yamamoto M, Okahisa Y, Sata A, Katsumoto E, Koeda M, Hirano Y, Nakataki M, Matsumoto J, Miura K, Hashimoto N, Makinodan M, Takahashi T, Nemoto K, Kishimoto T, Suzuki M, Sumiyoshi T, Hashimoto R.
    BJPsych Open. 8(4):e98, 1-9, 2022.6
  3. Probable progressive supranuclear palsy in a patient with chronic schizophrenia: A case report
    Kita A, Tsuji T, Koh J, Takahashi S, Yamamoto M, Sakamoto Y, Itogawa H, Kimoto S
    Exp Ther Med. 24(1):484, 2022.6.1
  4. Skipping Breakfast and Incidence of Frequent Alcohol Drinking in University Students in Japan: A Retrospective Cohort Study.
    Matsumura Y, Yamamoto R, Shinzawa M, Matsushita T, Yoshimura R, Otsuki N, Mizui M, Matsui I, Kaimori J, Sakaguchi Y, Ishibashi C, Ide S, Nakanishi K, Nishida M, Kudo T, Yamauchi-Takihara K, Nagatomo I, Moriyama T
    Nutrients. 14(13). 2022.6.27

2022年7月

  1. Characteristic of process analysis on instrumental activities of daily living according to the severity of cognitive impairment in community-dwelling older adults with Alzheimer's disease
    Tabira T, Hotta M, Maruta M, Ikeda Y, Shimokihara S, Han G, Yamaguchi T, Tanaka H, Ishikawa T, Ikeda M
    International Psychogeriatrics. 1-12. 2022.7.15
  2. Impaired neuronal integrity in traumatic brain injury detected by123I-iomazenil single photon emission computed tomography and MRI
    Kato H, Nakagawara J, Hachisuka K, Hatazawa J, Ikoma K, Suehiro E, Iida H, Ogasawara K, Iizuka O, Ishiai S, Ichikawa T, Nariai T, Okazaki T, Shiga T, Mori E
    J.Cereb. Blood Flow Metab. 7:271678X221113001, 2022.7
  3. Effect of donepezil for dementia prevention in Parkinson's disease with severe hyposmia (The DASH-PD study): A randomized long-term placebo-controlled trial
    Baba T, Takeda A, Murakami A, Koga T, Isomura T, Mori E; DASH-PD study group
    EClinicalMedicine. 51:101571, 2022.7.14

2022年8月

  1. Increased digital media use is associated with sleep problems among university students: A study during the COVID-19 pandemic in Japan
    Watanabe K, Adachi H, Yamamoto R, Fijino R, Ishimaru D, Kanayama D, Sakagami Y, Akamine S, Marutani N, mamiya Y, mashita M, Nakano N, Kudo T, Ikeda M
    Frontiers in Psychiatry. 29; 13:946265. 2022.8
  2. Biological basis and psychiatric symptoms in frontotemporal dementia.
    Mori K, Ikeda M
    Psychiatry Clin Neurosci. 76(8):351-360, 2022.8
  3. Association between Bone-Related Physiological Substances and Oral Function in Community-Dwelling Older People
    Nakamura M, Imaoka M, Tazaki F, Nakao H, Hida M, Kono R, Kanemoto H, Takeda M.
    Int J Environ Res Public Health. 19(17):10677. 2022.8.27
  4. Assessment of Noninvasive Brain Stimulation Interventions for Negative Symptoms of Schizophrenia: A Systematic Review and Network Meta-analysis
    Tseng PT, Zeng BS, Hung CM, Liang CS, Stubbs B, Carvalho AF, Brunoni AR, Su KP, Tu YK, Wu YC, Chen TY, Li DJ, Lin PY, Hsu CW, Chen YW, Suen MW, Satogami K, Takahashi S, Wu CK, Yang WC, Shiue YL, Huang TL, Li CT
    JAMA Psychiatry. 79(8):770-779, 2022.8.1
  5. Risk factors for unfavourable outcomes aftershunt surgery in patients with idiopathic normal-pressure hydrocephalus
    Kobayashi E, Kanno S, Kawakami N, Narita W, Saito M, Endo K, Iwasaki M, Kawaguchi T, Yamada S, Ishii K, Kazui H, Miyajima M, Ishikawa M, Mori E, Tominaga T, Tanaka F, Suzuki K
    Sci.Rep. 12(1):13921, 2022.8.17

2022年9月

  1. Characteristics of very late-onset schizophrenia-like psychosis as prodromal dementia with Lewy bodies: a cross-sectional study
    Kanemoto.H, Satake Y, Suehiro T, Taomoto D, Koizumi F, Sato S, Wada T, Matsunaga K, Shimosegawa E, Hashimoto M, Yoshiyama K, Ikeda M
    Alzheimer's Research & Therapy.14(1):137. 2022.9.22
  2. Secular trends in the prevalence of dementia based on a community-based complete enumeration in Japan: the Nakayama Study.
    Shimizu H, Mori T, Yoshida T, Tachibana A, Ozaki T, Yoshino Y, Ochi S, Sonobe N, Matsumoto T, Komori K, Iga J, Ninomiya T, Ueno S, Ikeda M
    Psychogeriatrics. 22(5):631-641. 2022.9
  3. Feasibility study of comfort with and use of sleep visualisation data from non-wearable actigraphy among psychiatric unit staff.
    Odachi R, Yamakawa M, Nakashima K, Kajiwara T, Takeshita Y, Iwase M, Tsukuda J, Ikeda M.
    Psychogeriatrics. 22(5):764-766. 2022.9
  4. Clinical utility of electroconvulsive therapy for the treatment of multidrug-resistant psychosis emerging in older adults: a case report.
    Satake Y, Sato S, Yoshiyama K, Shimura Y, Iwase M, Hashimoto M, Ikeda M
    Psychogeriatrics. 22(5):757-761. 2022.9.
  5. Cross-Disorder Analysis of Genic and Regulatory Copy Number Varia-tions in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disor-der.
    Kushima I, Nakatochi M, Aleksic B, Okada T, Kimura H, Kato H, Morikawa M, Inada T, Ishizuka K, Torii Y, Nakamura Y, Tanaka S, Imaeda M, Takahashi N, Yamamoto M, Iwamoto K, Nawa Y, Ogawa N, Iritani S, Hayashi Y, Lo T, Otgonbayar G, Furuta S, Iwata N, Ikeda M, Saito T, Ninomiya K, Okochi T, Hashimoto R, Yamamori H, Yasuda Y, Fujimoto M, Miura K, Itokawa M, Arai M, Miyashita M, Toriumi K, Ohi K, Shioiri T, Kitaichi K, Someya T, Watanabe Y, Egawa J, Takahashi T, Suzuki M, Sasaki T, Tochigi M, Nishimura F, Yamasue H, Kuwabara H, Wakuda T, Kato T A, Kanba S, Horikawa H, Usami M, Kodaira M, Watanabe K, Yoshikawa T, Toyota T, Yokoyama S, Munesue T, Kimura R, Funabiki Y, Kosaka H, Jung M, Kasai K, Ikegame T, Jinde S, Numata S, Kinoshita M, Kato T, Kakiuchi C, Yamakawa K, Suzuki T, Hashimoto N, Ishikawa S, Yamagata B, Nio S, Murai T, Son S, Kunii Y, Yabe H, Inagaki M, Goto YI, Okumura Y, Ito T, Arioka Y, Mori D, Ozaki N.
    Biol Psychiatry, 92(5):362-374, 2022.9.01

2022年10月

  1. Impact of age on the cerebrospinal fluid spaces: high-convexity and medial subarachnoid spaces decrease with age.
    Hidaka Y, Hashimoto M, Suehiro T, Fukuhara R, Ishikawa T, Tsunoda N, Koyama A, Honda K, Miyazawa Y, Yoshiura K, Boku S, Ishii K, Ikeda M, Takebayashi M
    Fluids and barriers of the CNS. 19(1) 82.2022.10.28
  2. Randomized, sham-controlled, clinical trial of repetitive transcranial magnetic stimulation for patients with Alzheimer's dementia in Japan
    Saitoh Y, Hosono K, Mano T, Takeya Y, Tagami S, Mori N, Matsugi A, Jono Y, Harada H, Yamada T, and Miyake A
    Front Aging Neurosci14:993306. 2022.10.13
  3. Clozapine treatment is associated with higher prescription rate of antipsychotic monotherapy and lower prescription rate of other con-comitant psychotropics: A real-world nationwide study.
    Ochi S, Tagata H, Hasegawa N, Yasui-Furukori N, Iga J I, Kashiwagi H, Kodaka F, Komatsu H, Tsuboi T, Tokutani A, Numata S, Ichihashi K, Onitsuka T, Muraoka H, Iida H, Ohi K, Atake K, Kishimoto T, Hori H, Takaesu Y, Takeshima M, Usami M, Makinodan M, Hashimoto N, Fujimoto M, Furihata R, Nagasawa T, Yamada H, Matsumoto J, Miura K, Kido M, Hishimoto A, Ueno S I, Watanabe K, Inada K, Hashimoto R.
    Int J Neuropsychopharmacol.25(10):818-826., 2022.10.25
  4. Two cases of steroid dementia showing partial recovery during two-year follow-up
    Ikeda N, Yamada S, Yamamoto M, Tanaka K, Fujii T, Tsuji T, Kimoto S, Takahashi S
    Psychiatry Clin Neurosci Reports. 2022.10.6
  5. Computational modeling of electric fields for prefrontal tDCS across patients with schizophrenia and mood disorders
    Uenishi S, Tamaki A, Yamada S, Yasuda K, Ikeda N, Mizutani-Tiebel Y, Keeser D, Padberg F, Tsuji T, Kimoto S, Takahashi S
    Psychiatry Res Neuroimaging.326:111547. 2022.10.7
  6. Multiple comparison of different noninvasive brain stimulation and pharmacologic interventions in patients with methamphetamine use disorders: a network meta-analysis of randomized controlled trials
    Wu MK, Satogami K, Liang CS, Stubbs B, Carvalho AF, Brunoni AR, Su K-P, Tu YK, Wu YC, Chen TY, Li DJ, Lin PY, Hsu CW, Chen YW, Suen MW, Zeng BY, Takahashi S, Tseng PT, Li CT
    Psychiatry Clin Neurosci. 6(12):633-643. 2022.10.8
  7. The Big Five personality traits and the fear of COVID-19 in predicting depression and anxiety among Japanese nurses caring for COVID-19 patients: A cross-sectional study in Wakayama prefecture
    Odachi R, Takahashi S, Sugawara D, Tabata M, Kajiwara T, Hironishi M, Buyo M
    PLoS One. 17(10):e0276803.2022.10.27
  8. Structural connectivity between the hippocampus and cortical/subcortical area relates to cognitive impairment in schizophrenia but not in mood disorders
    Ikeda N, Yamada S, Yasuda K, Uenishi S, Tamaki A, Ishida T, Tabata M, Tsuji T, Kimoto S, Takahashi S
    J Neuropsychol. 2022.10.28. Online ahead of print.

2022年11月

  1. Case report: Delusional infestation in dementia with Lewy bodies.
    Taomoto D, Kanemoto H, Satake Y, Yoshiyama K, Iwase M, Hashimoto M, Ikeda M.
    Front Psychiatry.13:1051067. 2022.11.10
  2. Usefulness of an online system to support daily life activities of outpatients with young-onset dementia: a case report.
    Nagata Y, Hotta M, Satake Y, Ishimaru D, Suzuki M, Ikeda M
    Psychogeriatrics. 22(6):890-894. 2022.11
  3. Differences by cognitive impairment in detailed processes for basic activities of daily living in older adults with dementia
    Shimokihara S, Tabira T, Hotta M, Tanaka H, Yamaguchi T, Maruta M, Han G, Ikeda Y, Ishikawa T, Ikeda M
    Psychogeriatrics. 22(6):859-868. 2022.11
  4. Association between globus pallidus volume and positive symptoms in schizophrenia.
    Ito S, Miura K, Miyayama M, Matsumoto J, Fukunaga M, Ishimaru K, Fujimoto M, Yasuda Y, Watanabe Y, Hashimoto R.
    Psychiatry and clinical neurosciences. 76(11):602-603, 2022.11
  5. Advanced aging effects on implicit motor imagery and its links to motor performance: An investigation via mental rotation of letters, hands, and feet.
    Muto H, Suzuki M, Sekiyama K
    Front Aging Neurosci. 14:1025667. 2022.11.17

2022年12月

  1. Cortical electrical activity changes in healthy aging using EEG-eLORETA analysis
    Aoki Y, Hata M, Iwase M, Ishii R, Pascual-Marqui RD, Yanagisawa T, Kishima H, Ikeda M
    Neuroimage: Reports. 2(4) 100143. 2022.12
  2. Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter study.
    Matsuda H, Okita K, Motoi Y, Mizuno T, Ikeda M, Sanjo N, Murakami K, Kambe T, Takayama T, Yamada K, Suehiro T, Matsunaga K, Yokota T, Tateishi U, Shigemoto Y, Kimura Y, Chiba E, Kawashima T, Tomo Y, Tachimori H, Kimura Y, Sato N.
    Ann Nucl Med. 36(12):1039-1049. 2022.12
  3. Treatment needs of dementia with Lewy bodies according to patients, caregivers, and physicians: a cross-sectional, observational, questionnaire-based study in Japan.
    Hashimoto M, Manabe Y, Yamaguchi T, Toya S, Ikeda M.
    Alzheimers Res Ther. 14(1):188. 2022.12.15.
  4. Mirror writing and cortical hypometabolism in Parkinson's disease
    Shinohara M, Yokoi K, Hirayama K, Kanno S, Hosokai Y, Nishio Y, Ishioka T, Otsuki M, Takeda A, Baba T, Aoki M, Hasegawa T, Kikuchi A, Narita W, Mori E, Suzuki K
    PLoS One. 17(12):e0279007, 2022.12.14

2022年・月不明

  1. The Diagnostic Patterns of Referring Physicians and Hospital Expert Psychiatrists Regarding Particular Frontotemporal Lobar Degeneration Clinical and Neuropathological Subtypes.
    Shinagawa S, Kawakami I, Takasaki E, Shigeta M, Arai T, Ikeda M.
    Alzheimers Dis. 88(2):601-608. 2022

2022年業績として掲載する2023年刊行・in press等

  1. Therapeutic reduction of GGGGCC repeat RNA levels by hnRNPA3 suppresses neurodegeneration in Drosophila models of C9orf72-linked ALS/FTD
    Taminato T, Takeuchi T*, Ueyama M, Mori K, Ikeda M, Mochizuki H, Nagai Y*
    Human Molecular Genetics (in press)
  2. RNA dysmetabolism and repeat associated non-AUG translation in Frontotemporal Lobar Degeneration/Amyotrophic Lateral Sclerosis due to C9orf72 hexanucleotide repeat expansion
    Mori K, Gotoh S, Uozumi R, Miyamoto T, Akamine S, Kawabe Y, Tagami S, Ikeda M
    JMA Journal. Vol.6:No.1. 2023